

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
SNY | NASDAQ | USD | Real-time | |
SANp | BATS Europe | EUR | Delayed | |
0O59 | London | EUR | Real-time | |
SNYN | Mexico | MXN | Delayed | |
SANF | Milan | EUR | Real-time | |
SASY | Frankfurt | EUR | Delayed | |
SASY | Xetra | EUR | Delayed | |
SASY | TradeGate | EUR | Delayed | |
SASY | Paris | EUR | Real-time |
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or derivatives. With a...
Interest rates in the US are going up. The country's red-hot inflation level has prompted the Federal Reserve to step in to achieve its dual mandate of "price stability and maximum sustainable...
When we look at the Sanofi (NASDAQ:SNY) chart, we can see that it’s been trading in a channel for the past week with support formed at $51.40 and resistance at $52.90. It was last found trading at...
The crowd is about to pile into monthly dividend stocks, and we’re going to beat them to it with three of the best of them—and grab ourselves hefty yields up to 7.7%, too. The three...
Sanofi (NASDAQ:SNY) SNY and partner Regeneron (NASDAQ:REGN) REGN announced positive top-line data from the second pivotal phase III study on their blockbuster medicine Dupixent (dupilumab) for...
Despite the success of COVID vaccines and medicines, the biotech sector underperformed the broader market in 2021. The Medical-Biomedical and Genetics industry declined 21.6% in 2021 against the...
BridgeBio Pharma (NASDAQ:BBIO), Inc. BBIO announced that it has entered into a non-exclusive clinical collaboration agreement with Amgen AMGN to evaluate the combination of its investigational SHP2...
LLY, one of the best-performing pharma stocks in 2021, was down over 6% in the first week of the new year. Wall Street concurs that innovation across its core therapeutic areas has meant increased...
For Immediate ReleaseChicago, IL – December 15, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest...
When the taper tantrum finally hits, these five dividends—up to 12.9%—are likely to directly benefit. Right now, their profits are being artificially suppressed by the Fed. Once this...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review